10x Genomics, Inc.
- TXG
- NASDAQ
- Biotechnology
- Single-Cell Genomics
- Spatial Genomics
- Genomic Instruments/Consumables
$69.56
Today −0.47%Quote Oct 20, 2026, 02:10 PM UTC
−8.76%over the last month
Max drawdown −28.5%From 1-month high −28.5%3 months +48.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About 10x Genomics
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems.
Where the money comes from
Q2 2026 revenue $300.1M
- Product And Service Revenue$149.1M49.7%
- Consumables$130.8M43.6%
- Service$10.7M3.6%
- Instruments$7.7M2.6%
- Licensing And Royalty Revenue$1.9M0.6%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
1,178
Founded
2012
Market value
$9.06B
Quote Oct 20
Floor
$64.76
6.9% below price
Resistance
$72.62
4.4% above price
Price vs analyst targets
22 analysts
Lowest target
$65.00Highest target
$110.00
$65.00Highest target
$110.00
- Price $69.56
- Average target $83.30
- Analysts' target range
The price is close to the lowest analyst target. Analysts' average target sits about 20% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TXGPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free